BioSpace News Archive

Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, and central nervous system (CNS) disorders, today announced that the Company has engaged New England Investors, LLC to serve as the out-licensing advisor for Envelta in the People’s Republic of China.

Eclipse Bioinnovations (Eclipsebio), a leading RNA genomics company developing and commercializing novel, data-driven technologies that interrogate RNA, today announced the launch of its eRibo™ suite of technologies, providing methods that improve upon differential expression analysis compared to the traditional Ribo-Seq.

BioSkryb Genomics, a pioneer in comprehensive single-cell multi-omic research solutions, has appointed Suresh Pisharody as its new CEO.

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) (“Nextleaf”, “OILS”, or the “Company”), a federally regulated manufacturer and distributor of cannabis extracts, has released its audited annual financial statements for the fiscal year ended September 30, 2022.

PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) (“PharmaDrug” or the “Company”), a specialty pharmaceutical company focused on the research, development and commercialization of psychedelics and other naturally-derived approved drugs, is pleased to announce that the Company has completed filing a PCT (Patent Cooperation Treaty)

CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid, announced its inclusion in the second annual “Innovation Momentum: The Global Top 100" report by LexisNexis®.

MicroTransponder®, Inc. announces that the Centers for Medicare and Medicaid Services awarded the Vivistim® Paired VNS™ System transitional pass-through status, expanding access to Medicare beneficiaries who are ischemic stroke survivors interested in using the breakthrough technology to help improve their hand and arm mobility.

CirrusMD, a leading provider of on-demand virtual care, today announced the CirrusMD Provider Network (CMDPN) has achieved the ISO/IEC 27001:2013 certification for its information security management system.

Optinose today announced that Peter Miller has stepped down as Chief Executive Officer and Board member, and that Ramy Mahmoud, MD, MPH has been appointed as Chief Executive Officer and Board member.

Emergent Health Corp. announced today the appointment of former Kraft Foods Director of National Accounts Charlie McMenamin to its Board of Directors.